Antibody Analytics

Antibody Analytics is a biotech startup dedicated to enhancing drug development through expert bioanalytical testing and adaptive solutions for complex molecular challenges. The company's slogan, "Enhancing drug development with expert bioanalytical testing and adaptive solutions for complex molecular challenges," reflects their commitment to providing tailored solutions for the pharmaceutical industry. Founded in 2015, Antibody Analytics specializes in bioanalytical testing, a critical aspect of drug development programs. Their expertise lies in collaborating with clients on intricate molecules, understanding the scientific nuances of assays, and navigating the regulatory landscape. The company's last investment, a Private Equity Round, took place on 02 November 2023, with NorthEdge Capital as the investor. This backing signifies confidence in the potential of Antibody Analytics and underscores their value proposition in the biotech ecosystem. The company's strategic focus on bioanalytical testing and strong investor support position them as a compelling player in the drug development industry's continued growth and innovation.